Medpace
$374.07
24H
Market Cap
Volume
Supply
Price Chart
About Medpace - MEDP
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides a range of clinical development services for the biotechnology, pharmaceutical, and medical device industries. The company specializes in the management of clinical trial processes from protocol design to the final regulatory submission.
What are Medpace's core values and mission statement?
Medpace Holdings, Inc., as a clinical contract research organization, emphasizes its commitment to accelerating the global development of safe and effective medical therapeutics. Their mission focuses on strong scientific leadership, exceptional operational delivery, and a tailored approach to clinical research, ensuring that they provide sponsors with high-quality data and efficient trial management.
Who founded Medpace and when?
Medpace Holdings, Inc. was founded by Dr. August Troendle in 1992.
Who leads Medpace?
Medpace Holdings, Inc. has been led by August J. Troendle, who is the founder, President, and Chief Executive Officer.
Where is Medpace located, and what is its base country?
Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio, United States, and its base country is the United States.
On which exchanges is Medpace traded?
Medpace Holdings, Inc. is traded on the NASDAQ Stock Market under the ticker symbol MEDP.
Historical data
Medpace (MEDP) Price Live Data
The live price of Medpace (MEDP) is $374.07, with a trading volume of 182,068 in the last 24 hours. Wrapstocks updates the MEDP price in real-time. Medpace is down -2.19% in the last 24 hours. The company has a live market cap of $11,589,885,952.00 and a supply of 30,983,201 MEDP stocks.
Medpace (MEDP) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 7 hours and 31 minutes.
